VirnetX (VHC -4.8%) is lower amidst reports the USPTO has rejected all of the claims in the...
Wednesday, January 16, 1:27 PM ETVirnetX (VHC -4.8%) is lower amidst reports the USPTO has rejected all of the claims in the company's '949 patent, which is being asserted in a suit against Apple, in a re-examination. If true, expect VirnetX to appeal; the company is also asserting other patents against Apple. Update: SA author Chris Hofmann points out the USPTO issued an action closing prosecution (.pdf) for claims in VirnetX's '181 patent, which is asserted in an ITC case against Apple. VirnetX has 30 days to respond to the rejections made.
TECH ETFs IN FOCUS
Latest Tech Articles